Monsanto Co. (NYSE:MON) was up 3.6% on Tuesday . The stock traded as high as $109.00 and last traded at $108.28, with a volume of 5,808,996 shares changing hands. The stock had previously closed at $104.50.

Several equities research analysts recently weighed in on MON shares. Zacks Investment Research upgraded Monsanto from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 3rd. Vetr upgraded Monsanto from a “sell” rating to a “hold” rating and set a $89.50 target price for the company in a report on Wednesday, May 4th. Berenberg Bank set a $110.00 target price on Monsanto and gave the company a “buy” rating in a report on Friday, May 13th. TheStreet upgraded Monsanto from a “hold” rating to a “buy” rating in a report on Thursday, May 12th. Finally, Piper Jaffray Cos. restated an “overweight” rating on shares of Monsanto in a report on Saturday, May 14th. Four research analysts have rated the stock with a sell rating, six have issued a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. Monsanto presently has a consensus rating of “Buy” and an average target price of $109.88.

The stock has a market cap of $46.86 billion and a PE ratio of 47.14. The stock has a 50-day moving average price of $104.75 and a 200-day moving average price of $97.90.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, June 29th. The company reported $2.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.40 by $0.23. The company earned $4.19 billion during the quarter, compared to analysts’ expectations of $4.49 billion. The business’s revenue for the quarter was down 8.5% compared to the same quarter last year. During the same period last year, the firm earned $2.39 EPS. Analysts predict that Monsanto Co. will post $4.45 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be issued a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.02%.

In related news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Monsanto stock. US Bancorp DE raised its position in Monsanto Co. (NYSE:MON) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 344,555 shares of the company’s stock after buying an additional 1,297 shares during the period. US Bancorp DE owned about 0.08% of Monsanto worth $33,946,000 as of its most recent SEC filing.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.